Nanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteers

References

• AbdelbaryAALiXEl-NabarawiMElassasyAJastiBComparison of nanomilling and coprecipitation on the enhancement of in vitro dissolution rate of poorly water-soluble model drug aripiprazolePharm Dev Technol201419449150023731085
   PubMed Web of Science ®Google Scholar
• LipinskiCAPoor aqueous solubility – an industry wide problem in drug discoveryAmerican Pharmaceutical Review200258285
   Google Scholar
• KesisoglouFPanmaiSWuYNanosizing – oral formulation development and biopharmaceutical evaluationAdv Drug Deliv Rev200759763164417601629
   PubMed Web of Science ®Google Scholar
• ChenYZhangGGNeillyJMarshKMawhinneyDSanzgiriYDEnhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68Int J Pharm20042861–2698015501003
   PubMed Web of Science ®Google Scholar
• AliSMUpadhyaySKMaheshwariANMR spectroscopic study of the inclusion complex of desloratadine with β-cyclodextrin in solutionJ Incl Phenom Macrocycl Chem2007593–4351355
   Web of Science ®Google Scholar
• ChaumeilJCMicronization: a method of improving the bioavailability of poorly soluble drugsMethods Find Exp Clin Pharmacol19982032112159646283
   PubMedGoogle Scholar
• Van EerdenbrughBVermantJMartensJASolubility increases associated with crystalline drug nanoparticles: methodologies and significanceMol Pharm2010751858187020822111
   PubMedGoogle Scholar
• RabinowBENanosuspensions in drug deliveryNat Rev Drug Discov20043978579615340388
   PubMed Web of Science ®Google Scholar
• AbdelbaryAALiXEl-NabarawiMElassasyAJastiBEffect of fixed aqueous layer thickness of polymeric stabilizers on zeta potential and stability of aripiprazole nanosuspensionsPharm Dev Technol201318373073523033924
   PubMed Web of Science ®Google Scholar
• MüllerRHMöschwitzerJBushrabFNManufacturing of nanoparticles by milling and homogenization techniquesGuptaRBKompellaUBNanoparticle Technology for Drug Delivery (Drugs and the Pharmaceutical Sciences) Book 159New YorkCRC Press20062151
   Google Scholar
• AliHSYorkPBlagdenNPreparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactorsInt J Pharm20093751–210711319481696
   PubMed Web of Science ®Google Scholar
• Van EerdenbrughBVermantJMartensJAA screening study of surface stabilization during the production of drug nanocrystalsJ Pharm Sci20099862091210318803265
   PubMed Web of Science ®Google Scholar
• Van EerdenbrughBVan den MooterGAugustijnsPTop-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid productsInt J Pharm20083641647518721869
   PubMed Web of Science ®Google Scholar
• MüllerRHJacobsCBuparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stabilityInt J Pharm20022371–215116111955813
   PubMed Web of Science ®Google Scholar
• MüllerRHBohmBHLNanosuspensionsMüllerRHBenitaSBohmBHEmulsions and Nanosuspensions for the Formulation of Poorly Soluble DrugsStuttgartMedpharm GmbH Scientific Publishers1998149174
   Google Scholar
• PatravaleVBDateAAKulkarniRMNanosuspensions: a promising drug delivery strategyJ Pharm Pharmacol200456782784015233860
   PubMed Web of Science ®Google Scholar
• KrauseKPMüllerRHProduction and characterisation of highly concentrated nanosuspensions by high pressure homogenisationInt J Pharm20012141–2212411282231
   PubMedGoogle Scholar
• ChingunpitukJNanosuspension technology for drug deliveryWalailak Journal of Science and Technology200742139153
   Google Scholar
• ToegelSHuangWPianaCSelection of reliable reference genes for qPCR studies on chondroprotective actionBMC Mol Biol200781317324259
   PubMed Web of Science ®Google Scholar
• O’NeilMJHeckelmanPEKochCBThe Merck Index, An Encyclopedia of Chemicals: Drugs and Biologicals14th edWhitehouse Station, NJMerck Research Laboratories2006
   Google Scholar
• AggarwalAKSinghSPhysicochemical characterization and dissolution study of solid dispersions of diacerein with polyethylene glycol 6000Drug Dev Ind Pharm201137101181119121449824
   PubMed Web of Science ®Google Scholar
• NicolasPTodMPadoinCPetitjeanOClinical pharmacokinetics of diacereinClin Pharmacokinet19983553473599839088
   PubMed Web of Science ®Google Scholar
• JainASinghSKSinghYSinghSDevelopment of lipid nanoparticles of diacerein, an antiosteoarthritic drug for enhancement in bioavailability and reduction in its side effectsJ Biomedl Nanotechnol201395891900
   PubMed Web of Science ®Google Scholar
• BattDKGaralaKCPreparation and evaluation of inclusion complexes of diacerein with β-cyclodextrin and hydroxypropyl β-cyclodextrinJ Incl Phenom Macrocycl Chem2013771–4471481
   Web of Science ®Google Scholar
• MaskiNKumaranAGirhepunjeKGhodePRandiveSPalRStudies on the preparation, characterization and solubility of β-cyclodextrin/diacerein inclusion complexesInternational Journal of Pharmacy and Pharmaceutical Sciences200912121135
   Google Scholar
• AbdelbaryAAElshafeeyAHEl-NabarawiMElassasyALiXJastiBComparative in vivo evaluation of aripiprazole coprecipitate, nanoparticles and marketed tablets in healthy human volunteers and in vitro-in vivo correlationCurrent Trends in Biotechnology and Pharmacy20115413971409
   Google Scholar
• XuYLiuXLianREnhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid-base neutralizationInt J Pharm20124381–228729522989976
   PubMedGoogle Scholar
• HecqJDeleersMFanaraDVranckxHAmighiKPreparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipineInt J Pharm20052991–216717715996838
   PubMed Web of Science ®Google Scholar
• CostaPSousa LoboJMModeling and comparison of dissolution profilesEur J Pharm Sci200113212313311297896
   PubMed Web of Science ®Google Scholar
• GaoBWangJWangDA novel preparation method for drug nanocrystals and characterization by ultrasonic spray-assisted electrostatic adsorptionInt J Nanomedicine201383927393524143097
   PubMed Web of Science ®Google Scholar
• SunJWangFSuiYEffect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q10 as naked nanocrystalsInt J Nanomedicine201275733574423166438
   PubMed Web of Science ®Google Scholar
• RahmanZZidanASKhanMARisperidone solid dispersion for orally disintegrating tablet: its formulation design and non-destructive methods of evaluationInt J Pharm20104001–2495820801200
   PubMedGoogle Scholar
• World Medical AssociationWorld Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjectsJAMA2013310202191219424141714
   PubMed Web of Science ®Google Scholar
• SmithPFThird international conference on harmonization of technical requirements for registration of pharmaceuticals for human use – a toxicologist’s perspectiveToxicol Pathol19962445195288864198
   PubMed Web of Science ®Google Scholar
• RoweRCSheskeyPJQuinnMEHandbook of Pharmaceutical Excipients6th edNYPharmaceutical Press2009
   Google Scholar
• ZambauxMFBonneauxFGrefRInfluence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion methodJ Control Release1998501–331409685870
   PubMed Web of Science ®Google Scholar
• YuWXieHA review on nanofluids: preparation, stability mechanisms, and applicationsJournal of Nanomaterials201220121
   Web of Science ®Google Scholar
• de LaatAWMBijsterboschHDCohen StuartMAFleerGJStruijkCWSolvency effects in polymer layers studied by electrokinetics: PVME as homopolymer and in an anionic diblock copolymer adsorbed on SiO2Colloids Surf A: Physicochem Eng Asp20001661–37989
   Web of Science ®Google Scholar
• HanFLiSYinRLiuHXuLEffect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: Nanostructured lipid carriersColloids Surf A: Physicochem Eng Asp20083151–3210216
   Web of Science ®Google Scholar
• de LimaLSAraujoMDMQuináiaSPMigliorineDWGarciaJRAdsorption modeling of Cr, Cd and Cu on activated carbon of different origins by using fractional factorial designChem Eng J20111663881889
   Web of Science ®Google Scholar
• KaushikRSaranSIsarJSaxenaRKStatistical optimization of medium components and growth conditions by response surface methodology to enhance lipase production by Aspergillus carneusJ Mol Catal B Enzym2006403–4121126
   Web of Science ®Google Scholar
• ChauhanBGuptaRApplication of statistical experimental design for optimization of alkaline protease production from Bacillus sp. RGR-14Process Biochemistry2004391221152122
   Web of Science ®Google Scholar
• AnnaduraiGLingLYLeeJFStatistical optimization of medium components and growth conditions by response surface methodology to enhance phenol degradation by Pseudomonas putidaJ Hazard Mat20081511171178
   PubMed Web of Science ®Google Scholar
• SinghGPaiRSDeviVKOptimization of pellets containing solid dispersion prepared by extrusion/spheronization using central composite design and desirability functionJ Young Pharm20124314615623112533
   PubMedGoogle Scholar
• PandyaVMPatelJKPatelDJFormulation and optimization of nanosuspensions for enhancing simvastatin dissolution using central composite designDissolution Technologies20111834045
   Web of Science ®Google Scholar
• MauludinRMüllerRHKeckCMDevelopment of an oral rutin nanocrystal formulationInt J Pharm20093701–220220919114097
   PubMed Web of Science ®Google Scholar
• JudefeindAde VilliersMMDrug loading into and in vitro release from nanosized drug delivery systemsde VilliersMMAramwitPKwonGSNanotechnology in Drug DeliveryNYSpringer2009129162
   Google Scholar
• KuniedaHSatoYRecent progress on HLB systemFribergSELindmannBOrganized Solutions: Surfactants in Science and Technology44NYCRC Press19926788
   Google Scholar
• JunghannsJUMüllerRHNanocrystal technology, drug delivery and clinical applicationsInt J Nanomedicine20083329530918990939
   PubMed Web of Science ®Google Scholar
• DolencAKristlJBaumgartnerSPlaninsekOAdvantages of celecoxib nanosuspension formulation and transformation into tabletsInt J Pharm20093761–220421219426794
   PubMedGoogle Scholar
• MosharrafMNyströmCThe effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugsInt J Pharm19951221–23547
   Web of Science ®Google Scholar
• BisratMNyströmCPhysicochemical aspects of drug release. VIII. The relation between particle size and surface specific dissolution rate in agitated suspensionsInt J Pharm1988471–3223231
   Google Scholar
• NiebergallPJMilosovichGGoyanJEDissolution rate studies. II. Dissolution of particles under conditions of rapid agitationJ Pharm Sci19635223624113938476
   PubMed Web of Science ®Google Scholar
• HongSBHwangBWYeomYKimSJUhYSChemical interactions of aluminophosphate molecular sieve with vanadium oxideInuiTNambaSTatsumiTChemistry of Microporous CrystalsAmsterdamElsevier1991179187
   Google Scholar
• SachanNKPushkarSGhoshSKEvaluation of assam bora rice as a natural mucoadhesive matrixing agent for controlled drug deliveryKhemaniLDSrivastavaMMSrivastavaSChemistry of Phytopotentials: Health, Energy and Environmental PerspectivesNYSpringer2012165170
   Google Scholar
• GaoLZhangDChenMZhengTWangSPreparation and characterization of an oridonin nanosuspension for solubility and dissolution velocity enhancementDrug Dev Ind Pharm200733121332133918097807
   PubMed Web of Science ®Google Scholar